Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical analysis of neck node metastasis in oral cavity cancer

  • Sharma, Aditi (Department of Oral and Maxillofacial Surgery, Kyungpook National University School of Dentistry) ;
  • Kim, Jin-Wook (Department of Oral and Maxillofacial Surgery, Kyungpook National University School of Dentistry) ;
  • Paeng, Jun-Young (Department of Oral and Maxillofacial Surgery, Samsung Medical Center)
  • Received : 2018.01.09
  • Accepted : 2018.03.22
  • Published : 2018.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study was to evaluate the neck node metastasis pattern and related clinical factors in oral cavity cancer patients. Materials and Methods: In total, 76 patients (47 males, 29 females) with oral squamous cell carcinoma (OSCC) who had no previous malignancies and were not undergoing neoadjuvant concomitant chemoradiotherapy or radiotherapy were selected for analysis. Results: Occult metastases were found in 8 of 52 patients with clinically negative nodes (cN0, 15.4%). Neck node metastases were found in 17 patients (22.4%). There was a statistically significant relationship between neck node metastasis and T stage (P=0.014) and between neck node metastasis and distant metastasis (Fisher's exact test, P=0.019). Conclusion: Neck node metastasis was significantly related to tumor size and distant metastasis during follow-up.

Keywords

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90. https://doi.org/10.3322/caac.20107
  2. Ren ZH, Wu HJ, Wang K, Zhang S, Tan HY, Gong ZJ. Anterolateral thigh myocutaneous flaps as the preferred flaps for reconstruction of oral and maxillofacial defects. J Craniomaxillofac Surg 2014;42:1583-9. https://doi.org/10.1016/j.jcms.2014.04.012
  3. Ren ZH, Wu HJ, Tan HY, Wang K, Zhang S. Transfer of anterolateral thigh flaps in elderly oral cancer patients: complications in oral and maxillofacial reconstruction. J Oral Maxillofac Surg 2015;73:534-40. https://doi.org/10.1016/j.joms.2014.09.021
  4. Ren ZH, Xu JL, Fan TF, Ji T, Wu HJ, Zhang CP. The harmonic scalpel versus conventional hemostasis for neck dissection: a meta-analysis of the randomized controlled trials. PLoS One 2015;10:e0132476. https://doi.org/10.1371/journal.pone.0132476
  5. Byers RM, El-Naggar AK, Lee YY, Rao B, Fornage B, Terry NH, et al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 1998;20:138-44. https://doi.org/10.1002/(SICI)1097-0347(199803)20:2<138::AID-HED7>3.0.CO;2-3
  6. Po Wing Yuen A, Lam KY, Lam LK, Ho CM, Wong A, Chow TL, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma-a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 2002;24:513-20. https://doi.org/10.1002/hed.10094
  7. Woolgar JA, Triantafyllou A, Lewis JS Jr, Hunt J, Williams MD, Takes RP, et al. Prognostic biological features in neck dissection specimens. Eur Arch Otorhinolaryngol 2013;270:1581-92. https://doi.org/10.1007/s00405-012-2170-9
  8. Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21:517-25. https://doi.org/10.1002/(SICI)1097-0347(199909)21:6<517::AID-HED4>3.0.CO;2-C
  9. Lydiatt DD, Robbins KT, Byers RM, Wolf PF. Treatment of stage I and II oral tongue cancer. Head Neck 1993;15:308-12. https://doi.org/10.1002/hed.2880150407
  10. Yuen AP, Wei WI, Wong YM, Tang KC. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997;19:583-8. https://doi.org/10.1002/(SICI)1097-0347(199710)19:7<583::AID-HED4>3.0.CO;2-3
  11. Keski-Santti H, Atula T, Tornwall J, Koivunen P, Makitie A. Elective neck treatment versus observation in patients with T1/T2 N0 squamous cell carcinoma of oral tongue. Oral Oncol 2006;42:96-101.
  12. Yuen AP, Ho CM, Chow TL, Tang LC, Cheung WY, Ng RW, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck 2009;31:765-72. https://doi.org/10.1002/hed.21033
  13. Capote A, Escorial V, Munoz-Guerra MF, Rodriguez-Campo FJ, Gamallo C, Naval L. Elective neck dissection in early-stage oral squamous cell carcinoma--does it influence recurrence and survival? Head Neck 2007;29:3-11. https://doi.org/10.1002/hed.20482
  14. Huang SF, Chang JT, Liao CT, Kang CJ, Lin CY, Fan KH, et al. The role of elective neck dissection in early stage buccal cancer. Laryngoscope 2015;125:128-33. https://doi.org/10.1002/lary.24840
  15. Kirita T, Omura K. Oral cancer: diagnosis and therapy. Tokyo: Springer; 2015:221-30.
  16. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 1994;168:494-8. https://doi.org/10.1016/S0002-9610(05)80109-6
  17. Leon X, Quer M, Orus C, del Prado Venegas M, Lopez M. Distant metastases in head and neck cancer patients who achieved locoregional control. Head Neck 2000;22:680-6. https://doi.org/10.1002/1097-0347(200010)22:7<680::AID-HED7>3.0.CO;2-J
  18. Lim JY, Lim YC, Kim SH, Kim JW, Jeong HM, Choi EC. Predictive factors of isolated distant metastasis after primary definitive surgery without systemic treatment for head and neck squamous cell carcinoma. Oral Oncol 2010;46:504-8. https://doi.org/10.1016/j.oraloncology.2010.02.005
  19. Garavello W, Ciardo A, Spreafico R, Gaini RM. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:762-6. https://doi.org/10.1001/archotol.132.7.762
  20. Liao CT, Wang HM, Chang JT, Ng SH, Hsueh C, Lee LY, et al. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 2007;110:1501-8. https://doi.org/10.1002/cncr.22959
  21. Reinisch S, Kruse A, Bredell M, Lubbers HT, Gander T, Lanzer M. Is lymph-node ratio a superior predictor than lymph node status for recurrence-free and overall survival in patients with head and neck squamous cell carcinoma? Ann Surg Oncol 2014;21:1912-8. https://doi.org/10.1245/s10434-014-3634-5
  22. Prabhu RS, Hanasoge S, Magliocca KR, Hall WA, Chen SA, Higgins KA, et al. Lymph node ratio influence on risk of head and neck cancer locoregional recurrence after initial surgical resection: implications for adjuvant therapy. Head Neck 2015;37:777-82. https://doi.org/10.1002/hed.23662
  23. Gil Z, Carlson DL, Boyle JO, Kraus DH, Shah JP, Shaha AR, et al. Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 2009;115:5700-10. https://doi.org/10.1002/cncr.24631
  24. Guo CB, Feng Z, Zhang JG, Peng X, Cai ZG, Mao C, et al. Supraomohyoid neck dissection and modified radical neck dissection for clinically node-negative oral squamous cell carcinoma: a prospective study of prognosis, complications and quality of life. J Craniomaxillofac Surg 2014;42:1885-90. https://doi.org/10.1016/j.jcms.2014.07.007
  25. Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, Werner JA, Sesterhenn AM. A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol 2011;47:320-4. https://doi.org/10.1016/j.oraloncology.2011.03.009
  26. Vandenbrouck C, Sancho-Garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic radical neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial. Cancer 1980;46:386-90. https://doi.org/10.1002/1097-0142(19800715)46:2<386::AID-CNCR2820460229>3.0.CO;2-9
  27. Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg 1989;158:309-13. https://doi.org/10.1016/0002-9610(89)90122-0
  28. Bryne M. Prognostic value of various molecular and cellular features in oral squamous cell carcinomas: a review. J Oral Pathol Med 1991;20:413-20. https://doi.org/10.1111/j.1600-0714.1991.tb00430.x
  29. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4. https://doi.org/10.1245/s10434-010-0985-4
  30. Silverberg E. Cancer statistics. 1986. CA Cancer J Clin 1986;36:9-25. https://doi.org/10.3322/canjclin.36.1.9
  31. Shimamoto H, Oikawa Y, Osako T, Hirai H, Mochizuki Y, Tanaka K, et al. Neck failure after elective neck dissection in patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2017;124:32-6. https://doi.org/10.1016/j.oooo.2017.03.003
  32. Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, et al. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168:391-4. https://doi.org/10.1016/S0002-9610(05)80082-0
  33. Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg 2002;128:58-62. https://doi.org/10.1001/archotol.128.1.58
  34. Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck 1997;19:14-9. https://doi.org/10.1002/(SICI)1097-0347(199701)19:1<14::AID-HED3>3.0.CO;2-Y
  35. Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg 1994;120:699-702. https://doi.org/10.1001/archotol.1994.01880310005001
  36. Okura M, Aikawa T, Sawai NY, Iida S, Kogo M. Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol 2009;45:908-11. https://doi.org/10.1016/j.oraloncology.2009.03.013
  37. Dias FL, Lima RA, Kligerman J, Farias TP, Soares JR, Manfro G, Sa GM. Relevance of skip metastases for squamous cell carcinoma of the oral tongue and the floor of the mouth. Otolaryngol Head Neck Surg 2006;134:460-5. https://doi.org/10.1016/j.otohns.2005.09.025
  38. Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon Z, Vourvachis M, et al. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Head Neck Oncol 2010;2:9. https://doi.org/10.1186/1758-3284-2-9
  39. Duvvuri U, Simental AA Jr, D'Angelo G, Johnson JT, Ferris RL, Gooding W, et al. Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx. Laryngoscope 2004;114:2228-34. https://doi.org/10.1097/01.mlg.0000149464.73080.20
  40. Dias FL, Kligerman J, Matos de Sa G, Arcuri RA, Freitas EQ, Farias T, et al. Elective neck dissection versus observation in stage I squamous cell carcinomas of the tongue and floor of the mouth. Otolaryngol Head Neck Surg 2001;125:23-9. https://doi.org/10.1067/mhn.2001.116188
  41. Marchioni DL, Fisberg RM, do Rosario M, Latorre DO, Wunsch V. Diet and cancer of the oral cavity and pharynx: a case-control study in Sao Paulo, Brazil. IARC Sci Publ 2002;156:559-61.
  42. Kuntz AL, Weymuller EA Jr. Impact of neck dissection on quality of life. Laryngoscope 1999;109:1334-8. https://doi.org/10.1097/00005537-199908000-00030
  43. Rastogi S, Sharma A, Choudhury R, Tripathi S, Al Wayli H, Amrithraj A, et al. Is superselective neck dissection safer than supraomohyoid neck dissection for oral carcinoma patients with N0 neck in terms of shoulder morbidity and recurrence rate? J Oral Maxillofac Surg 2018;76:647-55. https://doi.org/10.1016/j.joms.2017.08.002
  44. Giordano L, Sarandria D, Fabiano B, Del Carro U, Bussi M. Shoulder function after selective and superselective neck dissections: clinical and functional outcomes. Acta Otorhinolaryngol Ital 2012;32:376-9.
  45. Mashberg A, Meyers H. Anatomical site and size of 222 early asymptomatic oral squamous cell carcinomas: a continuing prospective study of oral cancer. II. Cancer 1976;37:2149-57. https://doi.org/10.1002/1097-0142(197605)37:5<2149::AID-CNCR2820370502>3.0.CO;2-G

Cited by

  1. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis vol.9, pp.None, 2018, https://doi.org/10.12688/f1000research.22941.1
  2. Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma vol.13, pp.None, 2018, https://doi.org/10.2147/cmar.s319048
  3. Suppurative mastoid lymphadenitis mimicking mastoiditis: a case report vol.47, pp.5, 2018, https://doi.org/10.5125/jkaoms.2021.47.5.398